HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald Trump’s inauguration on 20 January.

The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...

A federal pharmaceutical testing facility in St. Louis will remain open, despite appearing on DOGE’s list of scheduled office ...

Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation and Research (CDER) from 2020 until January, when she resigned just ahead of President Trump’s return to office.

Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.

Trump has made major cuts across several federal health agencies—including the FDA—in the name of government efficiency, resulting in thousands of layoffs. After taking the top spot at CDER ...

Cavazzoni was the head of the FDA’s Center for Drug Evaluation and Research (CDER), from 2020 until her departure in January. She was one of several top FDA officials who left the agency ahead ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory ...

MATTB provides assistance and training through outreach to industry. A: CDER's Division of Drug Information (DDI) serves as a focal point for public inquiries regarding human drug products.